Detalhe da pesquisa
1.
Tixagevimab/Cilgavimab as pre-exposure prophylaxis against SARS-CoV-2 in patients with hematological malignancies.
Front Oncol
; 13: 1212752, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37427126
2.
A successful treatment-free remission is achievable also by chronic myeloid leukemia patients lacking optimal requirements.
Blood Cancer J
; 14(1): 53, 2024 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38531834